Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced two new advances in MR-only workflows to advance head and neck cancer radiotherapy imaging and simulation. The company's artificial intelligence (AI) enabled MRCAT Head and Neck radiotherapy application, which allows the use of MR as the sole or primary imaging modality for radiotherapy planning in the treatment of soft tissue tumors in the head and neck, along with the brain, pelvis and prostate, has received FDA 510(k) clearance and is commercially available in the U.S.
Siemens Healthineers and UHealth - University of Miami Health System - announced a Value Partnership(1) agreement. This strategic relationship will further technological advancement and standardization of equipment at the health system, while allowing the university to create educational and training programs for clinicians and technologists. This unique agreement is the first of its kind in Florida.
Shared care record and population health management provider Orion Health has a new chief executive. Brad Porter will lead the transition to a new phase for the business after 30 years of Ian McCrae at the helm.
Speaking during his first visit to the United Kingdom in his new role, Porter said: "The UK has always been an important market for Orion Health globally and we remain committed to our UK partners and customers."
Digital speech biomarker company ki:elements has published validation results on the use of its ki:e speech biomarker for cognition (SB-C) in early Alzheimer’s disease in the "Karger - Digital Biomarkers" journal.(1)
Two European dementia studies - the Dutch DeepSpA study in collaboration with Maastricht University & the Scottish SPeAK study in collaboration with University of Edinburgh - helped to validate the psychometric properties of the SB-C.
Opinion Article by Mark Venables, Co-Founder, Highland Marketing.In our sector, problems are pretty much inevitable. Think about it. Healthcare technology is tricky stuff.
Cleveland Clinic and IBM have begun deployment of the first private sector onsite, IBM-managed quantum computer in the United States. The IBM Quantum System is to be located on Cleveland Clinic’s main campus in Cleveland.
The first quantum computer in healthcare, anticipated to be completed in early 2023, is a key part of the two organizations'10-year partnership aimed at fundamentally advancing the pace of biomedical research through high-performance computing.